Evidence map›Paper›PMID 32448344›Full record

ArticleCritical care (London, England)2020

Effect of flow and cannula size on generated pressure during nasal high flow.

Maximilian Pinkham, Stanislav Tatkov

2 registry-linked trialsAbstract readLetter
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04560257 naunknown statusnot on this map

Prone Positioning and High Flow Nasal Canula (HFNC) Therapy: A Game Changer in COVID-19 Outcome

TypeinterventionalSponsorLahore General HospitalRan2020 to 2020Enrolled30ConditionsSARS-CoV Infection, SARS (Severe Acute Respiratory Syndrome)ArmsHigh flow nasal cannula HFNC
NCT06257667 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Randomized Controlled Trial to Investigate the Effect of High Flow Nasal Cannula Treatment on Carbon Dioxide-levels in COPD- Patients With Acute Hypercapnic Respiratory Failure, Using Either OptiflowTM or Optiflow+DuetTM Nasal Cannula

TypeinterventionalSponsorAalborg University HospitalRan2024 to 2026Enrolled138ConditionsHypercapnic Respiratory Failure, COPDArmsRespiratory Support
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Asymmetrical nasal high flow ventilation improves clearance of COJournal of applied physiology (Bethesda, Md. : 1985) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maximilian PinkhamFisher & Paykel Healthcare Ltd, PO Box 14 348, Auckland, 1741, New Zealand.
Stanislav TatkovFisher & Paykel Healthcare Ltd, PO Box 14 348, Auckland, 1741, New Zealand. stanislav.tatkov@fphcare.co.nz.ORCID 0000-0002-2064-0481

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannulaCoronavirus InfectionsCOVID-19Equipment DesignHumansOxygen Inhalation TherapyPandemicsPneumonia, ViralPressureTreatment OutcomeAcute respiratory failureCOVID-19Nasal cannulaNasal high flowPositive airway pressure

Identifiers

PMID32448344
PMCPMC7245881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.